In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction
Brought to you by

Cytyc withdraws acquisition of Digene

Executive Summary

Cytyc, manufacturer of the Thin Prep Pap Test has agreed to acquire Digene (gene based diagnostics) in a stock and cash deal valued at approximately $553.9mm. Cytyc will pay $76.9mm in cash and issue 23.5mm common shares for all outstanding Digene equity.
Deal Industry
  • Biotechnology
    • Drug Discovery Tools
      • Genomics-Proteomics
  • In Vitro Diagnostics
    • Molecular Diagnostics & Genetic Testing
Deal Status
  • Withdrawn
Deal Type
  • Acquisition
    • Includes Contract
    • Intra-Biotech Deal
    • Payment Includes Stock
    • Payment Includes Cash
    • Full Acquisition

Related Companies

Advertisement
UsernamePublicRestriction

Register